300
Participants
Start Date
November 8, 2024
Primary Completion Date
January 31, 2025
Study Completion Date
March 31, 2025
TriVerity Test
Participants in the post-phase of the study will have a 2.5 ml whole blood draw obtained via venipuncture into a PAXgene® Blood RNA tube. Blood samples will be processed using the TriVerity Cartridge on the Myrna Instrument located in the ED.
RECRUITING
Johns Hopkins Department of Emergency Medicine, Baltimore
RECRUITING
OSF HealthCare Saint Francis Medical Center, Peoria
Lead Sponsor
Inflammatix
INDUSTRY